Does DURVALUMAB Cause Bladder cancer? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Bladder cancer have been filed in association with DURVALUMAB (IMFINZI). This represents 0.1% of all adverse event reports for DURVALUMAB.
9
Reports of Bladder cancer with DURVALUMAB
0.1%
of all DURVALUMAB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Bladder cancer From DURVALUMAB?
Of the 9 reports, 1 (11.1%) resulted in death, 1 (11.1%) required hospitalization.
Is Bladder cancer Listed in the Official Label?
Yes, Bladder cancer is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Bladder cancer?
RANITIDINE (41,984)
PIOGLITAZONE (7,295)
METFORMIN\PIOGLITAZONE (278)
ADALIMUMAB (268)
ETANERCEPT (225)
METHOTREXATE (179)
INFLIXIMAB (165)
APIXABAN (159)
VALSARTAN (144)
LENALIDOMIDE (120)
Which DURVALUMAB Alternatives Have Lower Bladder cancer Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE